Compounds > raloxifene hydrochloride
Page last updated: 2024-08-23

raloxifene hydrochloride and norethindrone

raloxifene hydrochloride has been researched along with norethindrone in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's18 (90.00)29.6817
2010's2 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arndt, T; Bonnar, J; Creatsas, G; Depypere, H; Erenus, M; Nickelsen, T; Quail, D; Rechberger, T1
Chondros, C; Christodoulakos, G; Creatsas, G; Dendrinos, S; Kouskouni, E; Panoulis, C1
Cohen, SB; Lidor, AL; Lipitz, S; Mashiach, S; Novikov, I; Rabinovici, J; Seidman, DS1
Botsis, D; Christodoulacos, G; Creatsas, G; Kassanos, D; Panoulis, C; Rizos, D1
Benedetti-Panici, P; Cano, A; de Villiers, T; Hillard, T; Lunde, T; Marinescu, B; Neven, P; Nickelsen, T; Peer, E; Quail, D; Tiitinen, A1
Aguas, F; Beck, H; Bosio-LeGoux, B; De Geyter, C; Glant, MD; Hottgenroth, A; Lévrier, M; Neven, P; Nickelsen, T; Quail, D; Schmitt, H; Thé, HS1
Christodoulakos, GE; Creatsas, GC; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Papadias, CA1
Botsis, D; Caramalis, G; Christodoulakos, G; Creatsas, G; Lambrinoudaki, I; Panoulis, C; Rizos, D; Sioulas, V1
Franke, HR; Vermes, I; Werner, HM1
Bacchi Modena, A; Baldini, M; Benassi, L; Dei Cas, A; Luciana Barilli, A; Manotti, C; Rinaldi, M; Sgarabotto, M1
Andersen, TO; Eilertsen, AL; Qvigstad, E; Sandset, PM; Sandvik, L1
Christodoulakos, GE; Creatsas, GC; Economou, EV; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Papadias, C; Vitoratos, N; Vlachou, SA1
Andersen, TO; Eilertsen, AL; Mowinckel, MC; Qvigstad, E; Sandset, PM; Sandvik, L1
Eilertsen, AL; Hemker, HC; Liestøl, S; Mowinckel, MC; Sandset, PM1
Cetin, A; Dane, B; Dane, C; Erginbas, M1
Alexandrou, AP; Christodoulakos, GE; Creatsas, GC; Economou, EV; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Vlachou, SA1
Eilertsen, AL; Karssemeijer, N; Qvigstad, E; Sandset, PM; Skaane, P1
Bruce, D; Frick, A; Robinson, J; Rymer, J; Ylikorkala, O1
Aravantinos, L; Augoulea, A; Creatsa, M; Kyroudi, A; Lambrinoudaki, I; Panoulis, C; Politi, E; Rizos, D; Sergentanis, TN; Sioulas, VD1
Dahm, AE; Eilertsen, AL; Goeman, J; Kierulf, P; Mowinckel, MC; Olstad, OK; Ovstebø, R; Sandset, PM; Skretting, G1

Trials

17 trial(s) available for raloxifene hydrochloride and norethindrone

ArticleYear
Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
    Climacteric : the journal of the International Menopause Society, 2001, Volume: 4, Issue:4

    Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Europe; Female; Fibrinogen; Humans; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Triglycerides

2001
Effects of estrogen-progestin and raloxifene therapy on nitric oxide, prostacyclin and endothelin-1 synthesis.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2002, Volume: 16, Issue:1

    Topics: Cardiovascular Diseases; Double-Blind Method; Endothelin-1; Epoprostenol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Nitric Oxide; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators

2002
Effect of raloxifene on the ovarian circulation in women after menopause.
    American journal of obstetrics and gynecology, 2002, Volume: 186, Issue:5

    Topics: Aged; Drug Combinations; Estradiol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Ovary; Raloxifene Hydrochloride; Regional Blood Flow; Selective Estrogen Receptor Modulators; Single-Blind Method; Vascular Resistance

2002
Transvaginal sonographic monitoring of the uterine effects of raloxifene and a continuous combined replacement therapy in postmenopausal women.
    Maturitas, 2002, May-20, Volume: 42, Issue:1

    Topics: Administration, Oral; Adult; Drug Administration Schedule; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome; Ultrasonography; Uterus

2002
A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetate.
    BJOG : an international journal of obstetrics and gynaecology, 2003, Volume: 110, Issue:2

    Topics: Aged; Double-Blind Method; Estradiol; Estrogen Antagonists; Female; Humans; Middle Aged; Norethindrone; Osteoporosis, Postmenopausal; Progesterone Congeners; Prospective Studies; Raloxifene Hydrochloride; Single-Blind Method; Time Factors; Treatment Outcome; Uterine Diseases; Uterine Hemorrhage

2003
Uterine effects of estrogen plus progestin therapy and raloxifene: adjudicated results from the EURALOX study.
    Obstetrics and gynecology, 2004, Volume: 103, Issue:5 Pt 1

    Topics: Algorithms; Double-Blind Method; Estradiol; Estrogens; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Uterus

2004
Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 18, Issue:5

    Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Cholesterol; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Greece; Humans; Lipids; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Triglycerides

2004
Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study.
    Thrombosis research, 2007, Volume: 119, Issue:1

    Topics: Aged; Body Mass Index; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Female; Hemostasis; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Time Factors

2007
Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation.
    Maturitas, 2006, Oct-20, Volume: 55, Issue:3

    Topics: Antineoplastic Agents, Hormonal; Blood Coagulation; Blood Coagulation Tests; Bone Density Conservation Agents; Drug Therapy, Combination; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Thromboembolism

2006
Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene.
    Atherosclerosis, 2007, Volume: 193, Issue:1

    Topics: Adult; Androgens; Atherosclerosis; Biomarkers; Cardiovascular System; Chemokine CCL2; Chemokine CCL5; Chemotaxis; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators

2007
Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis.
    Thrombosis research, 2007, Volume: 120, Issue:3

    Topics: Administration, Oral; Aged; Blood Coagulation; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Female; Fibrinolysis; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Retrospective Studies; Time Factors

2007
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
    Thrombosis and haemostasis, 2007, Volume: 97, Issue:6

    Topics: Activated Protein C Resistance; Administration, Oral; Blood Coagulation; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Protein C; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tablets; Thromboembolism; Treatment Outcome; Venous Thrombosis

2007
Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2007, Volume: 23, Issue:7

    Topics: Bone Density; Bone Density Conservation Agents; Collagen Type I; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Norethindrone; Osteocalcin; Osteoporosis; Peptides; Postmenopause; Raloxifene Hydrochloride

2007
Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
    Maturitas, 2008, Jan-20, Volume: 59, Issue:1

    Topics: Adult; Body Mass Index; Contraceptives, Oral, Synthetic; Estradiol; Estrogen Receptor Modulators; Estrogens; Estrogens, Conjugated (USP); Fas Ligand Protein; Female; Follicle Stimulating Hormone; Ghrelin; Hormone Replacement Therapy; Humans; Insulin; Leptin; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Sex Hormone-Binding Globulin

2008
Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method.
    BJOG : an international journal of obstetrics and gynaecology, 2008, Volume: 115, Issue:6

    Topics: Administration, Oral; Aged; Breast; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Hormone Replacement Therapy; Humans; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Organ Size; Postmenopause; Raloxifene Hydrochloride

2008
A comparison of hormone therapies on the urinary excretion of prostacyclin and thromboxane A2.
    Climacteric : the journal of the International Menopause Society, 2008, Volume: 11, Issue:6

    Topics: Cardiovascular Diseases; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Epoprostenol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Thromboxane A2

2008
A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women.
    Thrombosis research, 2012, Volume: 130, Issue:1

    Topics: Aged; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Gene Expression Regulation; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Raloxifene Hydrochloride

2012

Other Studies

3 other study(ies) available for raloxifene hydrochloride and norethindrone

ArticleYear
Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Maturitas, 2005, Apr-11, Volume: 50, Issue:4

    Topics: Adult; Aged; Androgens; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin Resistance; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Hormone-Binding Globulin; Testosterone

2005
Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
    Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:3

    Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured

2005
Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells?
    Climacteric : the journal of the International Menopause Society, 2012, Volume: 15, Issue:2

    Topics: Aged; Androstenedione; Cervix Uteri; Contraceptives, Oral, Synthetic; Cross-Sectional Studies; Epithelial Cells; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Estrogens; Female; Humans; Metaplasia; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Papanicolaou Test; Postmenopause; Raloxifene Hydrochloride; Statistics, Nonparametric; Vaginal Smears; Vascular Endothelial Growth Factor A

2012